By: Megan Molteni
Despite widespread skepticism, the National Science Foundation and DARPA have invested millions of dollars in organoid-based biocomputing


Megan Molteni is a science writer at STAT. She covers genomic medicine, neuroscience, and reproductive technology, with a keen interest in the intersection of science and public health. Her work has been featured in PBS, The Boston Globe, WIRED, and other notable publications, and she is recognized for her award-winning feature on aerosol science and Covid-19 public health policy.
Preston is the artificial intelligence that powers the Intelligent Relations PR platform. Meet Preston
United States (National)


Not enough data
Megan Molteni's coverage primarily revolves around scientific and healthcare topics, with a focus on data-driven reporting. Given her emphasis on citing data and press releases, she is likely to be particularly interested in pitches that provide access to exclusive or compelling research findings within the fields of CRISPR, genetic engineering, AI in medicine, gene therapies, and other innovative medical technologies.
Her articles also suggest an international scope as she covers global developments in science and healthcare. Therefore, experts from various geographical locations who can contribute unique insights into these evolving areas would find favor with her.
This information evolves through artificial intelligence and human feedback. Improve this profile .